Lates News

Every AI Express, Guojin Securities released a research report on October 31, giving a "buy" rating to Rongchang Biology (688331.SH). The main reasons for the rating include: 1) RC18 indications reaching a milestone; 2) smooth expansion of RC48 frontline, excellent data at the ESMO conference. (Daily Economic News)